Status:

COMPLETED

Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19)

Lead Sponsor:

Manchester University NHS Foundation Trust

Conditions:

Coronavirus Infection

COVID-19

Eligibility:

All Genders

18-100 years

Brief Summary

The United Kingdom and wider world is in the midst of the 2019 novel coronavirus (SARS-CoV-2) pandemic. Accurate diagnosis of infection, identification of immunity and monitoring the clinical progress...

Eligibility Criteria

Inclusion

  • Work Stream A (in-hospital; Group 1 and Group 2):
  • Group 1 Inclusion Criteria:
  • We will include participants (patients or staff):
  • That are 18 years or older
  • That will require testing for COVID-19 in the opinion of the treating clinician
  • That may have presented with acute symptoms of COVID-19 (e.g. fever, cough, dyspnoea, anosmia) or chest x-ray changes or they may be asymptomatic but require testing for other reasons
  • Group 2 Inclusion Criteria:
  • We will include participants:
  • That are 18 years or older
  • That have been admitted for another reason other than suspected SARS-CoV-2 infection, but when routinely swabbed they have been identified as positive for SARS-CoV-2 PCR
  • Work Stream B (Group 3):
  • We will include participants:
  • That are 18 years or older
  • EITHER:
  • They have been identified as positive for SARS-CoV-2 PCR through testing at national laboratory infrastructure OR
  • They have been identified as negative for SARS-CoV-2 PCR through testing at national laboratory infrastructure
  • Work Stream C (Group 4):
  • We will include participants:
  • That are 18 years or older
  • Who are undergoing testing for COVID-19, whether they are symptomatic or symptomatic for COVID-19
  • Exclusion Criteria for all Work Streams:
  • Patients where it is impossible/unsafe to obtain the required research samples
  • Prisoners
  • Patients where sampling is not feasible

Exclusion

    Key Trial Info

    Start Date :

    May 19 2020

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    December 1 2024

    Estimated Enrollment :

    8380 Patients enrolled

    Trial Details

    Trial ID

    NCT04408170

    Start Date

    May 19 2020

    End Date

    December 1 2024

    Last Update

    April 23 2025

    Active Locations (15)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 4 (15 locations)

    1

    Sandwell General Hospital Birmingham NHS Trust

    Birmingham, United Kingdom

    2

    University Hospitals of Derby and Burton NHS FT

    Derby, United Kingdom

    3

    Frimley Health NHS FT

    Frimley, United Kingdom

    4

    Airedale NHS FT

    Keighley, United Kingdom

    Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19) | DecenTrialz